The Clorox Company (FRA:CXX)
Germany · Delayed Price · Currency is EUR 91.00
-0.50 (-0.55%)
At close: Jan 30, 2026
The Clorox Company Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 6,771 | 7,104 | 7,093 | 7,389 | 7,107 | 7,341 | |
Revenue Growth (YoY) | -9.35% | 0.15% | -4.01% | 3.97% | -3.19% | 9.22% |
Cost of Revenue | 3,773 | 3,896 | 4,028 | 4,484 | 4,562 | 4,128 |
Gross Profit | 2,998 | 3,208 | 3,065 | 2,905 | 2,545 | 3,213 |
Selling, General & Admin | 1,857 | 1,896 | 1,985 | 1,921 | 1,679 | 1,809 |
Research & Development | 118 | 121 | 126 | 139 | 132 | 149 |
Other Operating Expenses | 12 | 6 | 33 | 33 | 22 | 23 |
Operating Expenses | 1,987 | 2,023 | 2,144 | 2,093 | 1,833 | 1,981 |
Operating Income | 1,011 | 1,185 | 921 | 812 | 712 | 1,232 |
Interest Expense | -90 | -88 | -90 | -90 | -106 | -99 |
Interest & Investment Income | 8 | 9 | 23 | 16 | 5 | 5 |
Earnings From Equity Investments | 3 | 4 | 5 | 4 | 6 | 5 |
Currency Exchange Gain (Loss) | -2 | -2 | -25 | -13 | -3 | -10 |
EBT Excluding Unusual Items | 930 | 1,108 | 834 | 729 | 614 | 1,133 |
Merger & Restructuring Charges | - | - | -32 | -60 | - | - |
Impairment of Goodwill | - | - | - | - | - | -228 |
Gain (Loss) on Sale of Investments | 18 | 18 | 20 | 14 | -21 | 110 |
Gain (Loss) on Sale of Assets | - | -118 | -224 | - | 14 | - |
Asset Writedown | - | - | - | -445 | - | -115 |
Other Unusual Items | - | - | -200 | - | - | - |
Pretax Income | 1,008 | 1,078 | 398 | 238 | 607 | 900 |
Income Tax Expense | 205 | 254 | 106 | 77 | 136 | 181 |
Earnings From Continuing Operations | 803 | 824 | 292 | 161 | 471 | 719 |
Net Income to Company | 803 | 824 | 292 | 161 | 471 | 719 |
Minority Interest in Earnings | -12 | -14 | -12 | -12 | -9 | -9 |
Net Income | 791 | 810 | 280 | 149 | 462 | 710 |
Net Income to Common | 791 | 810 | 280 | 149 | 462 | 710 |
Net Income Growth | 121.57% | 189.29% | 87.92% | -67.75% | -34.93% | -24.39% |
Shares Outstanding (Basic) | 123 | 124 | 124 | 124 | 123 | 126 |
Shares Outstanding (Diluted) | 124 | 124 | 125 | 124 | 124 | 127 |
Shares Change (YoY) | -0.75% | -0.41% | 0.50% | 0.22% | -2.67% | -0.29% |
EPS (Basic) | 6.42 | 6.56 | 2.25 | 1.21 | 3.75 | 5.65 |
EPS (Diluted) | 6.38 | 6.52 | 2.25 | 1.20 | 3.73 | 5.58 |
EPS Growth | 121.91% | 189.78% | 87.50% | -67.83% | -33.15% | -24.19% |
Free Cash Flow | 636 | 761 | 483 | 930 | 535 | 945 |
Free Cash Flow Per Share | 5.13 | 6.12 | 3.87 | 7.49 | 4.32 | 7.42 |
Dividend Per Share | 4.920 | 4.900 | 4.820 | 4.740 | 4.660 | 4.490 |
Dividend Growth | 1.65% | 1.66% | 1.69% | 1.72% | 3.79% | 4.66% |
Gross Margin | 44.28% | 45.16% | 43.21% | 39.31% | 35.81% | 43.77% |
Operating Margin | 14.93% | 16.68% | 12.98% | 10.99% | 10.02% | 16.78% |
Profit Margin | 11.68% | 11.40% | 3.95% | 2.02% | 6.50% | 9.67% |
Free Cash Flow Margin | 9.39% | 10.71% | 6.81% | 12.59% | 7.53% | 12.87% |
EBITDA | 1,225 | 1,397 | 1,146 | 1,038 | 928 | 1,437 |
EBITDA Margin | 18.09% | 19.66% | 16.16% | 14.05% | 13.06% | 19.57% |
D&A For EBITDA | 214 | 212 | 225 | 226 | 216 | 205 |
EBIT | 1,011 | 1,185 | 921 | 812 | 712 | 1,232 |
EBIT Margin | 14.93% | 16.68% | 12.98% | 10.99% | 10.02% | 16.78% |
Effective Tax Rate | 20.34% | 23.56% | 26.63% | 32.35% | 22.41% | 20.11% |
Advertising Expenses | - | 770 | 832 | 734 | 709 | 790 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.